









市场行情
/
股票
/
nasdaq-axgn
/

AxoGen Inc

AXGN

31.980USD

+0.280+0.88%

收盘 12/19, 16:00（美东）报价延迟15分钟

1.47B总市值

亏损市盈率 TTM



AxoGen Inc

31.980

+0.280+0.88%

概览公司财务分析

概览

公司

财务

分析

关于 AxoGen Inc 公司

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc简介



公司代码AXGN

公司名称AxoGen Inc

上市日期Dec 17, 1986

CEODale (Michael Donald)

员工数量451

证券类型Ordinary Share

年结日Dec 17

公司地址13631 Progress Blvd.

城市ALACHUA

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编32615

电话13864626817

网址https://www.axogeninc.com/

公司代码AXGN

上市日期Dec 17, 1986

CEODale (Michael Donald)

AxoGen Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Erick Wayne Devinney

Chief Innovation Officer

172.26K

+13.50%

Ms. Lindsey Hartley

Chief Financial Officer

31.38K

+51.11%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

27.03K

+113.10%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

Mr. Paul G. Thomas

Independent Chairman of the Board

-100.00%

Mr. John H. Johnson

Independent Director

Ms. Kathy Weiler

Independent Director

Mr. Marc A. Began

Executive Vice President, Chief Compliance Officer, General Counsel

Mr. William P. (Bill) Burke

Independent Director

Mr. Alan M. Levine

Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Erick Wayne Devinney

Chief Innovation Officer

172.26K

+13.50%

Ms. Lindsey Hartley

Chief Financial Officer

31.38K

+51.11%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

27.03K

+113.10%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

Mr. Paul G. Thomas

Independent Chairman of the Board

-100.00%

Mr. John H. Johnson

Independent Director

收入明细

FY2023

FY2022

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

159.01M

0.00%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月15日周六

持股股东

股东类型

持股股东

占比

First Light Asset Management, LLC

12.59%

BlackRock Institutional Trust Company, N.A.

6.89%

The Vanguard Group, Inc.

5.79%

Morgan Stanley & Co. LLC

4.96%

ArrowMark Colorado Holdings, LLC

4.25%

其他

65.53%

持股股东

占比

First Light Asset Management, LLC

12.59%

BlackRock Institutional Trust Company, N.A.

6.89%

The Vanguard Group, Inc.

5.79%

Morgan Stanley & Co. LLC

4.96%

ArrowMark Colorado Holdings, LLC

4.25%

其他

65.53%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

40.33%

Investment Advisor

29.37%

Hedge Fund

14.38%

Research Firm

6.35%

Individual Investor

5.37%

Family Office

1.76%

Bank and Trust

0.35%

Pension Fund

0.33%

Sovereign Wealth Fund

0.13%

其他

1.63%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

342

42.08M

97.83%

+8.74K

2025Q3

350

42.06M

101.71%

+627.35K

2025Q2

344

41.40M

98.61%

+1.26M

2025Q1

339

40.15M

93.21%

-2.27M

2024Q4

327

37.35M

99.16%

-1.08M

2024Q3

305

37.98M

92.55%

+3.00M

2024Q2

285

37.71M

96.69%

+1.44M

2024Q1

290

36.54M

95.40%

-4.68M

2023Q4

299

34.97M

92.73%

+437.14K

2023Q3

304

34.60M

92.75%

-2.09M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

First Light Asset Management, LLC

4.53M

9.84%

+55.03K

+1.23%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

3.10M

6.74%

-26.22K

-0.84%

Jun 30, 2025

The Vanguard Group, Inc.

2.72M

5.92%

+191.79K

+7.58%

Jun 30, 2025

Morgan Stanley & Co. LLC

1.93M

4.2%

+348.58K

+21.98%

Jun 30, 2025

ArrowMark Colorado Holdings, LLC

1.63M

3.53%

+34.80K

+2.19%

Jun 30, 2025

Soleus Capital Management, L.P.

1.46M

3.17%

+13.28K

+0.92%

Jun 30, 2025

Wasatch Global Investors Inc

1.43M

3.12%

+659.15K

+85.09%

Jun 30, 2025

Balyasny Asset Management LP

1.93M

4.2%

+1.25M

+183.91%

Jun 30, 2025

Assenagon Asset Management S.A.

1.29M

2.8%

+265.95K

+25.99%

Sep 30, 2025

Armistice Capital LLC

1.11M

2.42%

+573.04K

+106.46%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

ROBO Global Healthcare Technology & Innovation ETF

3.51%

State Street SPDR S&P Health Care Equipment ETF

2.3%

iShares Neuroscience and Healthcare ETF

2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

0.97%

Invesco NASDAQ Future Gen 200 ETF

0.74%

JPMorgan Fundamental Data Science Small Core ETF

0.21%

iShares Micro-Cap ETF

0.19%

Fidelity Enhanced Small Cap ETF

0.18%

Principal U.S. Small-Cap ETF

0.15%

Franklin US Small Cap Multifactor Index ETF

0.14%

ROBO Global Healthcare Technology & Innovation ETF

占比3.51%

State Street SPDR S&P Health Care Equipment ETF

占比2.3%

iShares Neuroscience and Healthcare ETF

占比2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

占比0.97%

Invesco NASDAQ Future Gen 200 ETF

占比0.74%

JPMorgan Fundamental Data Science Small Core ETF

占比0.21%

iShares Micro-Cap ETF

占比0.19%

Fidelity Enhanced Small Cap ETF

占比0.18%

Principal U.S. Small-Cap ETF

占比0.15%

Franklin US Small Cap Multifactor Index ETF

占比0.14%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

AxoGen Inc的前五大股东是谁？



AxoGen Inc 的前五大股东如下：
First Light Asset Management, LLC持有股份：4.53M，占总股份比例：9.84%。
BlackRock Institutional Trust Company, N.A.持有股份：3.10M，占总股份比例：6.74%。
The Vanguard Group, Inc.持有股份：2.72M，占总股份比例：5.92%。
Morgan Stanley & Co. LLC持有股份：1.93M，占总股份比例：4.20%。
ArrowMark Colorado Holdings, LLC持有股份：1.63M，占总股份比例：3.53%。